Medication

FILE - This is an April 30, 2020, file photo showing Gilead Sciences headquarters in Foster City, Calif. The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries. Gilead Sciences announced the price Monday, June 29 for remdesivir, and said the price would be $3,120 for patients with private insurance. It will sell for far less in poorer countries where generic drugmakers are being allowed to make it. (AP Photo/Ben Margot, File)
July 01, 2020 - 3:33 pm
LONDON (AP) — Public health experts on Wednesday criticized the U.S. for securing a large supply of the only drug licensed so far to treat COVID-19. The U.S. government announced this week that it had an agreement with Gilead Sciences to make the bulk of their production of remdesivir available to...
Read More
FILE - This is an April 30, 2020, file photo showing Gilead Sciences headquarters in Foster City, Calif. The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries. Gilead Sciences announced the price Monday, June 29 for remdesivir, and said the price would be $3,120 for patients with private insurance. It will sell for far less in poorer countries where generic drugmakers are being allowed to make it. (AP Photo/Ben Margot, File)
June 29, 2020 - 11:54 am
The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries. Gilead Sciences announced the price Monday for...
Read More
Dr. Robert Redfield, director of the Centers for Disease Control and Prevention, left, Director of the National Institute of Allergy and Infectious Diseases Dr. Anthony Fauci, second from left, listen during a House Committee on Energy and Commerce on the Trump administration's response to the COVID-19 pandemic on Capitol Hill in Washington on Tuesday, June 23, 2020. (Sarah Silbiger/Pool via AP)
June 23, 2020 - 1:40 pm
WASHINGTON (AP) — Dr. Anthony Fauci said Tuesday he is cautiously optimistic there will be a COVID-19 vaccine by the end of the year or early 2021, but warned that the next few weeks will be critical to tamping down coronavirus hot spots around the country. Fauci and other top health officials also...
Read More
FILE - In this Jan. 27, 2018 file photo, Honduran President Juan Orlando Hernandez, left, stands with his wife Ana Garcia, during the presidential inauguration ceremony for his second term at the National Stadium in Tegucigalpa, Honduras. Hernández and his wife have tested positive for COVID-19, the Central American leader said late Tuesday, June 16, 2020, in a television message. (AP Photo/Fernando Antonio, File)
June 17, 2020 - 3:07 pm
TEGUCIGALPA, Honduras (AP) — Honduran President Juan Orlando Hernández was hospitalized Wednesday with pneumonia, hours after announcing that he and his wife had tested positive for COVID-19. Francis Contreras, spokesman for the National System of Risk Management, said in a news conference that...
Read More
FILE - In this April 9, 2020 file photo, a chemist displays hydroxychloroquine tablets in New Delhi, India. U.S. regulators are revoking emergency authorization for malaria drugs promoted by President Donald Trump for treating COVID-19. The Food and Drug Administration said Monday, June 15 that the drugs hydroxychloroquine and chloroquine are unlikely to be effective in treating the coronavirus. (AP Photo/Manish Swarup, File)
June 15, 2020 - 5:27 pm
WASHINGTON (AP) — U.S. regulators on Monday revoked emergency authorization for malaria drugs promoted by President Donald Trump for treating COVID-19 amid growing evidence they don’t work and could cause serious side effects. The Food and Drug Administration said the drugs hydroxychloroquine and...
Read More
FILE - This Monday, April 6, 2020 file photo shows an arrangement of hydroxychloroquine pills in Las Vegas. On Friday, June 5, 2020, leaders of a large study in the United Kingdom that is rigorously testing the malaria drug hydroxychloroquine and other medicines for hospitalized COVID-19 patients say they will stop putting people on the drug because it’s clear it isn’t helping. (AP Photo/John Locher)
June 05, 2020 - 12:34 pm
Leaders of a large study in the United Kingdom that is rigorously testing the malaria drug hydroxychloroquine and other medicines for hospitalized COVID-19 patients say they will stop putting people on the drug because it’s clear it isn’t helping. Results released Friday from 1,542 patients showed...
Read More
FILE - This April 7, 2020 file photo shows a bottle of hydroxychloroquine tablets in Texas City, Texas. Several authors of a large study that raised safety concerns about malaria drugs for coronavirus patients have retracted the report, saying independent reviewers were not able to verify information that’s been widely questioned by other scientists. A retraction in the journal Lancet on Thursday, June 4, 2020 involved a May 22 report on hydroxychloroquine and chloroquine, drugs long used for preventing or treating malaria but whose safety and effectiveness for COVID-19 are unknown. (AP Photo/David J. Phillip, File)
June 04, 2020 - 4:23 pm
Several authors of a large study that raised safety concerns about malaria drugs for coronavirus patients have retracted the report, saying independent reviewers were not able to verify information that’s been widely questioned by other scientists. Thursday’s retraction in the journal Lancet...
Read More
Fans of two distinct soccer clubs join forces for an anti-government protest in Sao Paulo, Brazil, Sunday, May 31, 2020. Police used tear gas to disperse anti-government protesters in Brazil's largest city as they began to clash with small groups loyal to President Jair Bolsonaro. (AP Photo/Andre Penner)
May 31, 2020 - 6:49 pm
WASHINGTON (AP) — The U.S. has sent to Brazil more than 2 million doses of a malaria drug touted by President Donald Trump as potentially protecting against and treating the coronavirus, even though scientific evidence has not backed up those uses. No large, rigorous scientific studies have found...
Read More
Families with their children play along the Paseo de la Castellana in Madrid, Spain, Saturday, May 30, 2020. Spanish authorities are reporting no setbacks in their gradual easing of restrictions on movement over this past month, as some regions prepare to further loosen limits from June 1. (AP Photo/Manu Fernandez)
May 31, 2020 - 5:37 pm
The Latest on the coronavirus pandemic. The new coronavirus causes mild or moderate symptoms for most people. For some, especially older adults and people with existing health problems, it can cause more severe illness or death. TOP OF THE HOUR: — US sends Brazil malaria drug unproven for COVID-19...
Read More
This image made available by the U.S. Food and Drug Administration on Thursday, May 28, 2020 shows a label for the drug metformin. U.S. health regulators are telling five drugmakers to recall versions of the widely used diabetes medication after testing revealed elevated levels of a contaminant linked to cancer in several lots. (FDA via AP)
May 29, 2020 - 12:46 pm
WASHINGTON (AP) — U.S. health regulators are telling five drugmakers to recall their versions of a widely used diabetes medication after laboratory tests found elevated levels of a contaminant linked to cancer. The Food and Drug Administration said late Thursday that several batches of the drug...
Read More

Pages